(Q42142585)

English

A phase II trial evaluating the efficacy and safety of efavirenz in metastatic castration-resistant prostate cancer

scientific article published on 29 October 2014

In more languages
default values for all languages
No label defined

No description defined

Statements

A phase II trial evaluating the efficacy and safety of efavirenz in metastatic castration-resistant prostate cancer (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit